⏳
Showing Q1 2025 data
Springhill Fund Asset Management (HK) Co Ltd's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Springhill Fund Asset Management (HK) Co Ltd
•CIK: 1911270•Filing: Q1 2025
**Springhill Fund Asset Management (HK) Co Ltd** manages $21M across a concentrated portfolio of 19 positions. The fund exhibits significant exposure to biotechnology and healthcare, with top holdings including VRNA at $4.0M and SMMT at $2.4M. Further notable allocations include JANX ($2.1M) and REGN ($1.6M), indicating a focused, high-conviction approach within specialized sectors. This structure suggests active, deep-dive research into niche, high-growth life science opportunities.
Total AUM
$20.9M
QoQ Performance
-66.1%
Positions
19
Top 10 Concentration
82.9%
Latest Filing
Q1 2025
Top Holdings Allocation
VRNA
SMMT
JANX
REGN
NBIX
IM8N
SLNO
JAZZ
VRNA19.3%
SMMT11.5%
JANX10.2%
REGN7.9%
NBIX7.2%
IM8N7.0%
SLNO6.8%
JAZZ5.9%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other96.8%
Healthcare3.2%
🚪 Exited Positionssold since Q4 2024
+6 more exited positions
Changes from Q4 2024
NEW13 new positions
↑2 increased
↓4 decreased
Historical Filings
Q1 2025Q4 2024